Patients with MGUS are at risk to develop lymphoproliferative diseases such as myeloma or malignant lymphoma. They should be re-examined annually and at those times the following tests should be obtained:
- CBC, serum creatinine, calcium
- Serum and 24 h urine protein electrophoreses
- Skeletal survey (optional after 3-5 years of observation with no evidence of progression)